The results of several studies have shown that GPR56-TG2 interaction impeded melanoma growth, angiogenesis and metastasis, whereas GPR56 binding to collagen-III promoted the metastasis of breast cancer cells to bone [31,32,33,100]. This evidence concerns the gene ADGRG1 and breast carcinoma.